Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian share markets recover
Thu, 31 Oct 01:30 pm

After trading flat, Indian share markets recovered and are trading in the positive territory in the post-noon trading session. Majority of the sectoral indices are trading in the green with consumer durables, metal and banking stocks being the biggest gainers. Pharma, FMCG and power are the only stocks trading in the red.

BSE-Sensex is up 42 points and NSE-Nifty is trading 16 points up. BSE Mid Cap is trading up 0.8% and BSE Small Cap index is trading up 0.5%. The rupee is trading at 61.4 to the US dollar.

Majority of the power stocks are trading in the red with JaiPrakash Power and Power Grid Corporation being the biggest losers. However, CESC Ltd and Torrent Power are among the few stocks trading in the green. As per a leading financial daily, Power Grid Corporation Ltd (PGCL) has said that it would invest Rs 28.2 bn in four projects. The company will invest Rs 13.6 bn in 'Eastern Region Strengthening Scheme-V' project that is expected to be commissioned in 30 months. An amount of Rs 13.2 bn would be expended on 'Inter-Regional System Strengthening Scheme in WR and NR (Part A)' project likely to go on-stream in 36 months. PGCL will be developing a 'Transmission System' for Solapur at an estimated cost of Rs 633.2 m and will be commissioned in 24 months. Additionally, the company will procure telecom equipment, operation support system and other telecom network requirements at a cost of Rs 763 m. The Company Board gave its approval to the investment proposals at the Board meeting held on 23 October.

Most of the Indian pharma stocks are trading in green with Elder Pharma and JB Chemicals being the leading gainers. Cadila healthcare has declared September quarter results. The company has reported topline growth of 12.5% YoY with large part of sales growth coming from export formulations and export API segments. Barring Japan, all the geographies witnessed growth above 20% for the quarter. The domestic sales witnessed muted growth of 4.8% YoY for the quarter. On the margins front, EBITDA margins remained flat at 14.9%. Profit after tax jumped by 93.4% YoY. This was due to decline in finance costs and tax expenses. The tax rate for the quarter stood at 5.0% vs 32.3% in 2QFY13. Cadila's stock is currently trading up by 2.3%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian share markets recover". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.